title: Simultaneous occurrence of papulonecrotic tuberculid and erythema induratum in a patient with pulmonary tuberculosis.
abstract: Although papulonecrotic tuberculid is an uncommon cutaneous manifestation of tuberculosis (TB) associated with Mycobacterium tuberculosis infection, the simultaneous occurrence of papulonecrotic tuberculid and erythema induratum is even rarer. Papulonecrotic tuberculid occurs predominantly in young adults and is characterized by eruptions of necrotizing papules that heal with varioliform scars. Histopathologic findings include wedge-shaped necrosis of the dermis, poorly formed granulomatous infiltration, and vasculitis. Stainings and culture for acid-fast bacilli from skin biopsies are usually negative for M. tuberculosis, although the eruptions resolve with antitubercular therapy. Few patients with papulonecrotic tuberculid, especially with concurrent occurrence of erythema induratum, have been reported in the English literature. Here we report a case of a 12-year-old girl with simultaneous occurrence of papulonecrotic tuberculid and erythema induratum accompanying pulmonary TB.
authors.affiliation: Department of Dermatology, Pusan National University, School of Medicine, Busan, Korea.
authors.forename: Gun-Wook
authors.initials: GW
authors.lastname: Kim
authors.forename: Hyun-Je
authors.initials: HJ
authors.lastname: Park
authors.forename: Hoon-Soo
authors.initials: HS
authors.lastname: Kim
authors.forename: Hyun-Woo
authors.initials: HW
authors.lastname: Chin
authors.forename: Su-Han
authors.initials: SH
authors.lastname: Kim
authors.forename: Hyun-Chang
authors.initials: HC
authors.lastname: Ko
authors.forename: Moon-Bum
authors.initials: MB
authors.lastname: Kim
authors.forename: Byung-Soo
authors.initials: BS
authors.lastname: Kim
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D015897:Comorbidity; D003937:Diagnosis, Differential; D004891:Erythema Induratum / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D009169:Mycobacterium tuberculosis; D012867:Skin / Q000473:pathology*; D014382:Tuberculosis, Cutaneous / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000995:Antitubercular Agents